ERK signalling: a master regulator of cell behaviour, life and fate

H Lavoie, J Gagnon, M Therrien - Nature reviews Molecular cell biology, 2020 - nature.com
The proteins extracellular signal-regulated kinase 1 (ERK1) and ERK2 are the downstream
components of a phosphorelay pathway that conveys growth and mitogenic signals largely …

Phenotype plasticity as enabler of melanoma progression and therapy resistance

I Arozarena, C Wellbrock - Nature Reviews Cancer, 2019 - nature.com
Malignant melanoma is notorious for its inter-and intratumour heterogeneity, based on
transcriptionally distinct melanoma cell phenotypes. It is thought that these distinct …

Stromal changes in the aged lung induce an emergence from melanoma dormancy

ME Fane, Y Chhabra, GM Alicea, DA Maranto… - Nature, 2022 - nature.com
Disseminated cancer cells from primary tumours can seed in distal tissues, but may take
several years to form overt metastases, a phenomenon that is termed tumour dormancy …

[HTML][HTML] Toward minimal residual disease-directed therapy in melanoma

F Rambow, A Rogiers, O Marin-Bejar, S Aibar, J Femel… - Cell, 2018 - cell.com
Many patients with advanced cancers achieve dramatic responses to a panoply of
therapeutics yet retain minimal residual disease (MRD), which ultimately results in relapse …

MITF—the first 25 years

CR Goding, H Arnheiter - Genes & development, 2019 - genesdev.cshlp.org
All transcription factors are equal, but some are more equal than others. In the 25 yr since
the gene encoding the microphthalmia-associated transcription factor (MITF) was first …

[HTML][HTML] WNT signaling in melanoma

A Gajos-Michniewicz, M Czyz - International journal of molecular sciences, 2020 - mdpi.com
WNT-signaling controls important cellular processes throughout embryonic development
and adult life, so any deregulation of this signaling can result in a wide range of pathologies …

Melanoma subtypes: genomic profiles, prognostic molecular markers and therapeutic possibilities

R Rabbie, P Ferguson, C Molina‐Aguilar… - The Journal of …, 2019 - Wiley Online Library
Melanoma is characterised by its ability to metastasise at early stages of tumour
development. Current clinico‐pathologic staging based on the American Joint Committee on …

[HTML][HTML] The master role of microphthalmia-associated transcription factor in melanocyte and melanoma biology

A Kawakami, DE Fisher - Laboratory investigation, 2017 - Elsevier
Certain transcription factors have vital roles in lineage development, including specification
of cell types and control of differentiation. Microphthalmia-associated transcription factor …

[HTML][HTML] Inhibiting drivers of non-mutational drug tolerance is a salvage strategy for targeted melanoma therapy

MP Smith, H Brunton, EJ Rowling, J Ferguson… - Cancer cell, 2016 - cell.com
Once melanomas have progressed with acquired resistance to mitogen-activated protein
kinase (MAPK)-targeted therapy, mutational heterogeneity presents a major challenge. We …

[HTML][HTML] MITF in normal melanocytes, cutaneous and uveal melanoma: a delicate balance

MC Gelmi, LE Houtzagers, T Strub, I Krossa… - International journal of …, 2022 - mdpi.com
Microphthalmia-associated transcription factor (MITF) is an important regulator of
melanogenesis and melanocyte development. Although it has been studied extensively in …